seed
Stage
1
Investors
About
Crucible Therapeutics is a UK-based biotechnology company developing novel RNA-targeting therapies to treat neurodegenerative diseases, specifically Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD).
Explore Crucible Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.